![](/img/cover-not-exists.png)
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)
Cresswell, Fiona V., Ssebambulidde, Kenneth, Grint, Daniel, te Brake, Lindsey, Musabire, Abdul, Atherton, Rachel R., Tugume, Lillian, Muzoora, Conrad, Lukande, Robert, Lamorde, Mohammed, Aarnoutse, RoVolume:
3
Language:
english
Journal:
Wellcome Open Research
DOI:
10.12688/wellcomeopenres.14691.1
Date:
July, 2018
File:
PDF, 573 KB
english, 2018